Please use this identifier to cite or link to this item:
http://elea.unisa.it/xmlui/handle/10556/6221
Title: | Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis |
Authors: | Rosato, Valerio Monteleone, Palmiero Persico, Marcello |
Keywords: | Cirrhosis;NAFLD;Untargeted metabolomics |
Issue Date: | 7-May-2021 |
Publisher: | Universita degli studi di Salerno |
Abstract: | Introduction: Non-Alcoholic Fatty Liver Disease encompasses a spectrum of diseases ranging from simple steatosis to steatohepatitis (or NASH), up to cirrhosis and hepatocellular carcinoma(HCC). The challenge is to recognize the more severe and/or progressive pathology. A reliable non-invasive method does not exist. Untargeted metabolomics is a novel method to discover biomarkers and give insights on diseases pathophysiology. Objectives: we applied metabolomics to understand if simple steatosis, steatohepatitis and cirrhosis in NAFLD patients have peculiar metabolites profiles that can differentiate them among each-others and from controls. Methods: Metabolomics signatures were obtained from 307 subjects from two separated enrollments. The first collected samples from 69 controls and 144 patients (78 steatosis, 23 NASH, 15 NASH-cirrhosis, 8 HCV-cirrhosis, 20 cryptogenic cirrhosis). The second, used as validation-set, enrolled 44 controls and 50 patients (34 steatosis, 10 NASH and 6 NASH-cirrhosis). The “Partial-Least-Square Discriminant-Analysis” (PLS-DA) was used to reveal class separation in metabolomics profiles between patients and controls and among each class of patients, and to reveal the metabolites contributing to class differentiation. Results: Several metabolites were selected as relevant, in particular: Glycocholic acid, Taurocholic acid, Phenylalanine, branched-chain amino acids increased at the increase of the severity of the disease from steatosis to NASH, NASH-cirrhosis, while glutathione decreased (p<0.001 for each). Moreover, an ensemble machine learning (EML) model was built using 10 different classification models. EML showed accuracy>80% in NAFLD evolution steps prediction. Conclusions: Metabolomics profiles of NAFLD patients could be a useful tool to non-invasively diagnose NAFLD and discriminate among the various stages of the disease, giving insights into its pathophysiology. [edited by Author] |
Description: | 2019 - 2020 |
URI: | http://elea.unisa.it:8080/xmlui/handle/10556/6221 http://dx.doi.org/10.14273/unisa-4309 |
Appears in Collections: | Medicina traslazionale dello sviluppo e dell’invecchiamento attivo |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
tesi di dottorato V. Rosato.pdf | tesi di dottorato | 1,05 MB | Adobe PDF | View/Open |
tesi di dottorato - presentazione V. Rosato.pptx | tesi di dottorato - presentazione | 22,51 MB | Microsoft Powerpoint XML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.